Inovio Pharmaceuticals Inc
NASDAQ:INO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc
Stock-Based Compensation
Inovio Pharmaceuticals Inc
Stock-Based Compensation Peer Comparison
ABBV
GILD
AMGN
VRTX
REGN
Competitive Stock-Based Compensation Analysis
Latest Figures & CAGR of Competitors
| Company | Stock-Based Compensation | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Inovio Pharmaceuticals Inc
NASDAQ:INO
|
Stock-Based Compensation
$9.8m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
10%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Stock-Based Compensation
$782m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
13%
|
CAGR 10-Years
13%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Stock-Based Compensation
$788m
|
CAGR 3-Years
7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
11%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Stock-Based Compensation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Stock-Based Compensation
$650.7m
|
CAGR 3-Years
15%
|
CAGR 5-Years
14%
|
CAGR 10-Years
16%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Stock-Based Compensation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Inovio Pharmaceuticals Inc's Stock-Based Compensation?
Stock-Based Compensation
9.8m
USD
Based on the financial report for Mar 31, 2024, Inovio Pharmaceuticals Inc's Stock-Based Compensation amounts to 9.8m USD.
What is Inovio Pharmaceuticals Inc's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 10Y
10%
Over the last year, the Stock-Based Compensation growth was -48%. The average annual Stock-Based Compensation growth rates for Inovio Pharmaceuticals Inc have been -23% over the past three years , -1% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet
